Evidence map›Paper›PMID 30679749›Full record

ArticleScientific reports2019

HSPA12A targets the cytoplasmic domain and affects the trafficking of the Amyloid Precursor Protein receptor SorLA.

Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E Tóth, Mette Nyegaard, Camilla Gustafsen, Morten S Nielsen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Peder MadsenDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark. pm@biomed.au.dk.
Toke Jost IsaksenDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.
Piotr SiupkaDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.
Andrea E TóthDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.ORCID 0000-0001-6122-919X
Mette NyegaardDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.ORCID 0000-0003-4973-8543
Camilla GustafsenDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.
Morten S NielsenDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark. mn@biomed.au.dk.ORCID 0000-0001-9863-9694
Aarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SorLA and Sortilin are multifunctional receptors involved in endocytosis and intracellular sorting of different and unrelated ligands. SorLA has recently attracted much attention as a novel strong risk gene for Alzheimer's disease, and much effort is currently being put into understanding the underlying molecular mechanism. Trafficking of SorLA and Sortilin are mediated by interacting with AP-1, AP-2, GGA 1-3 and the retromer complex. Although these cytosolic adaptor proteins all bind to both SorLA and Sortilin, a large fraction of intracellular Sortilin and SorLA are located in different subcellular vesicles. This indicates that unknown specialised adaptor proteins targeting SorLA for trafficking are yet to be discovered. We have identified HSPA12A as a new adaptor protein that, among Vps10p-D receptors, selectively binds to SorLA in an ADP/ATP dependent manner. This is the first described substrate of HSPA12A, and we demonstrate that the binding, which affects both endocytic speed and subcellular localisation of SorLA, is mediated by specific acidic residues in the cytosolic domain of SorLA. The identification of the relatively unknown HSPA12A as a SorLA specific interaction partner could lead to novel insight into the molecular mechanism of SorLA, and re-emphasises the role of heat shock proteins in neurodegenerative diseases.

Indexed as

Adaptor Proteins, Vesicular TransportAmino Acid SequenceAnimalsAstrocytesHEK293 CellsHSP70 Heat-Shock ProteinsHumansLDL-Receptor Related ProteinsMembrane Transport ProteinsMiceMice, Inbred C57BLProtein BindingProtein DomainsProtein TransportSortilinSubstrate SpecificityAdaptor Proteins, Vesicular TransportHSP70 Heat-Shock ProteinsHSPA12A protein, humanLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, humanSortilin

Identifiers

PMID30679749
PMCPMC6345817
OpenAlexW2940344757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.